Category: Medmonitor

83 posts found

FDA Approves New Formulation of Combogesic

The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.

Medmonitor

New Depression Product and Diabetes Generic Approvals

Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.

Medmonitor

Tornado Damages Pfizer Pharmaceutical Plant, Drug Shortages May Follow

As other Pfizer plants shift gears to make up for this damage, overall drug manufacturing may slow in some areas.

Medmonitor

FDA Publishes Guidance on Clinical Trials for Psychedelic Drugs

These guidelines advise researchers on study design and other considerations as they develop medications that contain psychedelics.

Medmonitor

Brixadi Approved for Opioid Use Disorder

A new buprenorphine injection will be available for weekly or monthly dosages, administered by providers.

Medmonitor

Drug Recalls for Pain Medications

Teva is recalling certain lots of fentanyl buccal tablets, while Family Dollar is recalling Advil that was not kept at proper temperature.

Medmonitor

FDA Approves First Over-the-Counter Naloxone Nasal Spray

Patients will no longer need a prescription for this opioid overdose antidote.

Medmonitor

FDA Approves Combogesic for Short Term Management of Mild to Moderate Pain

A new combination of acetaminophen and ibuprofen will soon hit the market.

Medmonitor

HIV Medications: New Approval and News of Discontinuations

Sunlenca approved for treatment-resistant populations, but a number of other drugs will cease production, some of which are included in PEP guidelines.

Medmonitor

FDA Approves Drug That Can Delay Onset of Type 1 Diabetes

Tzield (teplizumab-mzwv) injections can delay onset by several months or years.

Medmonitor

Wave of Generic Approvals That Impact Workers’ Comp

First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.

Medmonitor

FDA Advises Against NSAID Use in Pregnant Women at 20 Weeks and Later

The potential for low amniotic fluid can cause significant health issues.

Medmonitor

Auvelity Approved for Major Depressive Disorder

This antidepressant can yield results as soon as one week, which could generate popularity.

Medmonitor

FDA Authorizes New COVID-19 Vaccine

Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.

Medmonitor

FDA Recalls Morphine Sulfate ER Due to Potentially Deadly Label Mix-Up

A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.

Prev 1 2 3 4 5 6 Next